Download MendeleyStructural basis for the design of potent and species-specific inhibitors of 3-hydroxy-3-methylglutaryl CoA synthases.
Pojer, F., Ferrer, J.L., Richard, S.B., Nagegowda, D.A., Chye, M.L., Bach, T.J., Noel, J.P.(2006) Proc Natl Acad Sci U S A 103: 11491-11496
- PubMed: 16864776
- DOI: https://doi.org/10.1073/pnas.0604935103
- Primary Citation of Related Structures:
2F82, 2F9A, 2FA0, 2FA3 - PubMed Abstract:
3-Hydroxy-3-methylglutaryl CoA synthase (HMGS) catalyzes the first committed step in the mevalonate metabolic pathway for isoprenoid biosynthesis and serves as an alternative target for cholesterol-lowering and antibiotic drugs. We have determined a previously undescribed crystal structure of a eukaryotic HMGS bound covalently to a potent and specific inhibitor F-244 [(E,E)-11-[3-(hydroxymethyl)-4-oxo-2-oxytanyl]-3,5,7-trimethyl-2,4-undecadienenoic acid]. Given the accessibility of synthetic analogs of the F-244 natural product, this inhibited eukaryotic HMGS structure serves as a necessary starting point for structure-based methods that may improve the potency and species-specific selectivity of the next generation of F-244 analogs designed to target particular eukaryotic and prokaryotic HMGS.
Organizational Affiliation:
Howard Hughes Medical Institute, The Jack H. Skirball Center for Chemical Biology and Proteomics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
